MED
MEDIFAST INC
MEDIFAST INC historical holders
total: 3
Polen Capital Management MEDIFAST INC transactions over time
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Held since:
- 2019 Q1
- Held for:
- 4 quarters
- Latest activity:
- 2020 Q1
Polen Capital Management has been an institutional investor in MEDIFAST INC (MED) since 2019 Q1. According to 2026 Q1 report, Polen Capital Management doesn't hold any shares. The fund/company first acquired MED in 2019 Q1, initially purchasing 4,459 shares. Since the initial investment, Polen Capital Management has made 4 more transactions in this position.
When did Polen Capital Management exit their MED position?
Polen Capital Management no longer holds MEDIFAST INC (MED). They sold off their entire position in 2020 Q1, closing out an investment that began in 2019 Q1.
When did Polen Capital Management first invest in MED?
Polen Capital Management first invested in MEDIFAST INC (MED) in 2019 Q1 at the reported quarter-end price of $127.61 per share, acquiring 4,459 shares in their initial purchase.
What is Polen Capital Management's average cost basis for MED?
Based on historical transaction data, Polen Capital Management's estimated cost basis for MEDIFAST INC (MED) is approximately $125.12 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $125.12
- Weighted AVG sell price:
- $109.65
MED transactions history by Polen Capital Management
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2020 Q1
|
0.00%
|
$109.65
|
-100% (-5,636)
|
|||
|
2019 Q4
|
0.00%
|
$109.65
|
+15.90% (+773)
|
|||
|
2019 Q3
|
0.00%
|
$103.64
|
+0.37% (+18)
|
|||
|
2019 Q2
|
0.00%
|
$128.38
|
+8.66% (+386)
|
|||
|
2019 Q1
|
0.00%
|
$127.61
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.